
Precigen Financial Ratios 2025-2010 | PGEN
Brief overview of Precigen's financial ratios
The review covers five available annual periods spanning 2020 to 2025.
Market valuation is represented by P/S 100.19x (median 56.57x), P/B 46.4x (median 4.75x). Valuation is 476.7% above five-year reference levels. The premium requires support from earnings and returns.
Current measures of operating quality are ROE -12%, ROA -161.2%, ROCE -5.3%. Returns below zero mean resources are not producing positive profit. Recovery in operating results is the main reference point.
The cash cycle accelerated by 120.6 days to 91.2 days. Less capital is tied up in operations.
What the ratios show
Precigen combines weak profitability with valuation above its historical norm, leaving limited cushion.
Annual Financial Ratios Precigen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.9 | -6.6 | -3.7 | 8.2 | -5.5 | -8.3 | -2.3 | -2.0 | -13.6 | -13.3 | -38.3 | -34.8 | -34.5 | - | - | - |
P/S |
100.2 | 211.5 | 56.6 | 8.6 | - | 44.4 | 8.2 | 6.2 | 6.9 | 13.0 | 18.6 | 39.6 | 56.6 | - | - | - |
EPS |
-1.4 | -0.5 | -0.4 | 0.1 | -0.5 | -1.0 | -2.1 | -3.9 | -1.0 | -1.6 | -0.8 | -0.8 | -1.4 | -18.8 | -18.9 | - |
EV (Enterprise Value) |
1.07 B | 879 M | 377 M | 317 M | 719 M | 1.62 B | 1.07 B | 1.23 B | 1.83 B | 2.79 B | 3.38 B | 2.99 B | 1.38 B | 463 M | 316 M | -17.4 M |
EBITDA per Share |
-0.34 | -0.49 | -0.38 | 0.05 | 0.07 | 0.1 | -0.963 | -3.18 | -0.75 | -0.853 | -1.16 | -0.6 | -1.24 | - | - | - |
EV/EBITDA |
-10.0 | -6.7 | -4.1 | 29.5 | 44.0 | -24.0 | -6.1 | -2.7 | -17.1 | -24.1 | -24.1 | -47.6 | -25.5 | - | - | - |
PEG |
0.02 | 0.03 | 0.02 | 0.48 | -0.27 | -0.39 | -0.05 | 0.01 | -0.36 | 0.12 | -4.54 | -0.85 | -0.38 | - | - | - |
P/B |
46.4 | 12.4 | 3.0 | 1.8 | 4.8 | 21.1 | 10.4 | 2.7 | 3.0 | 4.4 | 4.7 | 7.4 | 3.7 | - | - | - |
P/CF |
-11.0 | -12.2 | -5.3 | -3.6 | -9.1 | -18.4 | -4.3 | -6.0 | -10.6 | -28.3 | 141.2 | -108.6 | -24.4 | - | - | - |
ROE % |
-1198.41 | -327.68 | -80.93 | 22.41 | -85.86 | -253.85 | -449.48 | -140.37 | -21.93 | -33.31 | -12.17 | -21.27 | -10.63 | - | - | - |
ROA % |
-161.15 | -86.88 | -63.49 | 13.10 | -25.61 | -54.20 | -70.72 | -71.12 | -13.82 | -19.66 | -8.60 | -14.20 | -8.30 | - | - | - |
ROCE % |
-528.46 | -350.61 | -84.19 | - | - | - | -52.10 | -68.00 | -15.80 | -14.65 | -16.21 | -13.23 | -12.90 | - | - | - |
Current Ratio |
1.2 | 1.8 | 4.6 | 2.4 | 1.4 | 1.3 | 1.9 | 4.6 | 1.9 | 3.3 | 4.3 | 3.7 | 9.5 | - | - | - |
DSO |
91.2 | 85.0 | 55.1 | 15.7 | - | 211.8 | 105.5 | 63.8 | 63.0 | 81.2 | 109.9 | 148.5 | 113.0 | - | - | - |
DIO |
- | - | - | - | - | - | 95.7 | 123.7 | 119.1 | 125.2 | 151.7 | 488.7 | - | - | - | - |
DPO |
- | - | - | - | - | - | 35.2 | 77.4 | 50.6 | 50.2 | 28.4 | 118.8 | - | - | - | - |
Operating Cycle |
91.2 | 85.0 | 55.1 | 15.7 | - | 211.8 | 201.2 | 187.5 | 182.1 | 206.4 | 261.6 | 637.2 | - | - | - | - |
Cash Conversion Cycle |
91.2 | 85.0 | 55.1 | 15.7 | - | 211.8 | 166.0 | 110.1 | 131.5 | 156.2 | 233.2 | 518.5 | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Precigen
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.06 | -0.02 | -1.06 | -0.09 | -0.18 | - | -0.09 | -0.23 | -0.1 | - | -0.08 | -0.08 | -0.1 | - | 0.44 | -0.09 | -0.1 | - | -0.15 | -0.1 | -0.09 | -0.23 | -0.18 | -0.26 | -0.35 | -1.09 | -0.35 | -0.25 | -0.4 | -2.59 | -0.44 | -0.51 | -0.36 | -0.23 | -0.33 | -0.16 | -0.26 | -0.37 | -0.24 | -0.42 | -0.55 | -0.28 | -0.34 | -0.37 | 0.26 | 0.19 | -0.53 | -0.53 | 0.04 | -0.13 | 0.15 | -2.45 | -7.54 | -6.52 | -4.66 | -3.99 | -3.55 | - | - | - | - |
EBITDA per Share |
0.07 | -0.01 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.02 | - | 0.05 | 0.04 | 0.02 | -0.19 | -0.06 | -0.01 | -0.07 | -0.42 | -0.1 | -0.06 | -0.23 | -1.68 | -0.32 | -0.25 | -0.35 | -0.22 | -0.18 | -0.17 | -0.2 | -0.27 | -0.09 | -0.1 | -0.3 | -0.29 | 0.04 | -0.09 | -0.79 | -0.19 | -0.08 | -0.14 | -0.17 | -0.18 | -0.12 | -1.86 | -2.14 | -2.17 | -1.88 | -3.16 | - | - | - | - | - |
ROE % |
-270.22 | 68.87 | 64.76 | 278.11 | 181.20 | -203.95 | -217.36 | -186.28 | -62.44 | -37.98 | 23.33 | 5.05 | -8.80 | 3.54 | -19.13 | -93.03 | -71.25 | -45.18 | -107.20 | -128.45 | -180.39 | -253.85 | -427.80 | -458.66 | -448.18 | -449.48 | -307.34 | -248.34 | -212.30 | -140.37 | -51.65 | -43.29 | -28.77 | -21.93 | -24.70 | -22.43 | -27.69 | -33.31 | -30.14 | -30.48 | -27.58 | -12.17 | -2.57 | -10.76 | -18.43 | -21.27 | -29.49 | -11.56 | 0.34 | -10.63 | 2.32 | 4.47 | 11.23 | 9.62 | 6.37 | 5.14 | - | - | - | - | - |
ROA % |
-105.53 | -159.36 | -182.37 | -177.28 | -168.74 | -126.69 | -137.07 | -118.14 | -47.19 | -29.58 | 4.12 | 9.01 | 13.07 | 22.48 | 14.58 | -24.10 | -22.87 | -17.13 | -30.38 | -31.86 | -40.66 | -54.20 | -78.09 | -80.48 | -75.20 | -70.72 | -81.13 | -77.37 | -77.99 | -71.12 | -26.80 | -23.48 | -16.56 | -13.82 | -15.25 | -13.62 | -16.58 | -19.66 | -18.34 | -19.18 | -18.15 | -8.60 | -2.00 | -7.26 | -12.15 | -14.20 | -20.07 | -7.62 | 0.15 | -8.30 | -26.10 | -42.92 | -52.55 | -20.40 | -13.51 | -10.90 | - | - | - | - | - |
ROCE % |
-64.26 | -133.83 | -104.21 | -104.21 | -104.21 | -104.21 | -104.21 | -104.21 | -104.21 | -104.21 | -104.21 | -104.21 | -104.21 | -104.21 | -104.21 | -104.21 | -104.21 | -104.21 | -104.21 | -104.21 | -104.21 | -128.92 | -172.41 | -186.55 | -198.93 | -232.58 | -210.64 | -180.57 | -164.28 | -120.43 | -51.50 | -41.57 | -34.47 | -25.84 | -26.69 | -23.45 | -20.99 | -22.34 | -21.48 | -17.48 | -15.84 | -21.16 | -21.13 | -23.90 | -26.09 | -18.18 | -18.09 | -17.46 | -16.65 | -15.82 | -7.16 | 1.25 | 11.74 | 3.83 | 5.13 | 6.61 | - | - | - | - | - |
Current Ratio |
1.3 | 1.2 | 1.3 | 0.9 | 1.1 | 1.9 | 3.0 | 2.4 | 3.6 | 4.6 | 4.4 | 5.0 | 4.2 | 2.4 | 2.2 | 1.2 | 1.3 | 1.4 | 1.5 | 1.6 | 1.8 | 1.3 | 1.3 | 1.3 | 1.3 | 1.2 | 1.2 | 1.2 | 1.2 | 2.1 | 2.1 | 2.1 | 2.1 | 2.8 | 2.8 | 2.8 | 2.8 | 2.5 | 2.5 | 2.5 | 2.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 5.3 | 5.3 | 5.3 | 5.3 | 2.3 | 2.3 | 2.3 | - | - | - | - | - |
DSO |
81.5 | 53.0 | - | - | - | - | - | - | - | - | - | 80.7 | 67.8 | - | 6.8 | 401.5 | 212.3 | - | 632.2 | 559.8 | 69.4 | 77.8 | 63.8 | 49.5 | 56.8 | 110.8 | 103.0 | 57.4 | 84.5 | 46.9 | 64.3 | 45.2 | 50.3 | 23.4 | 39.2 | 33.1 | 35.1 | 42.9 | 40.3 | 37.6 | 49.1 | 55.2 | 42.9 | 51.0 | 53.5 | 42.8 | 62.8 | 112.9 | 89.3 | 10.1 | 11.9 | 10.8 | 10.9 | 2.0 | 4.4 | 2.4 | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | 80.7 | 67.8 | - | 6.8 | 401.5 | 212.3 | - | 632.2 | 559.8 | 69.4 | 77.8 | 63.8 | 49.5 | 56.8 | 110.8 | 103.0 | 57.4 | 84.5 | 46.9 | 64.3 | 45.2 | 50.3 | 23.4 | 39.2 | 33.1 | 35.1 | 42.9 | 40.3 | 37.6 | 49.1 | 55.2 | 42.9 | 51.0 | 53.5 | 42.8 | 62.8 | 112.9 | 89.3 | 10.1 | 11.9 | 10.8 | 10.9 | 2.0 | 4.4 | 2.4 | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | 80.7 | 67.8 | - | 6.8 | 401.5 | 212.3 | - | 632.2 | 559.8 | 69.4 | 77.8 | 63.8 | 49.5 | 56.8 | 110.8 | 103.0 | 57.4 | 84.5 | 46.9 | 64.3 | 45.2 | 50.3 | 23.4 | 39.2 | 33.1 | 35.1 | 42.9 | 40.3 | 37.6 | 49.1 | 55.2 | 42.9 | 51.0 | 53.5 | 42.8 | 62.8 | 112.9 | 89.3 | 10.1 | 11.9 | 10.8 | 10.9 | 2.0 | 4.4 | 2.4 | - | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Precigen, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.